Recurrent World Health Organization (WHO) Grade II Glioma
3 clinical trials · Condition
◉ Watch Recurrent World Health Organization (WHO) Grade II Glioma
| Record | Firm | Date |
|---|---|---|
| Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021) (NCT04485559) | University of California, San Francisco | 2020-12-09 |
| Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms (NCT04044937) | Thomas Hope | 2018-10-29 |
| Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma (NCT04540107) | Susan Chang | 2017-01-11 |
Track Recurrent World Health Organization (WHO) Grade II Glioma automatically
Every clearance here is in the API, with alerts when new ones post.